Arterial innervation in development and disease

Science Translational Medicine

Volumn 6, Issue 252, 2014, Pages

  Eichmann, Anne ^a,b   Brunet, Isabelle ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PSL RESEARCH UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMIN; BONE MORPHOGENETIC PROTEIN; CATECHOLAMINE; DOPAMINE BETA MONOOXYGENASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 3; ENDOTHELIN RECEPTOR; NERVE GROWTH FACTOR; NETRIN 1; NEU DIFFERENTIATION FACTOR; NEUROTROPHIN 3; STROMAL CELL DERIVED FACTOR 1; TYROSINE 3 MONOOXYGENASE; VASCULOTROPIN;

ANGIOGENESIS; ARTERIAL INNERVATION; BLOOD PRESSURE REGULATION; BLOOD VESSEL INNERVATION; BLOOD VESSEL TONE; CATECHOLAMINE EXCRETION; CRITICAL LIMB ISCHEMIA; EMBRYO DEVELOPMENT; HEMATOPOIETIC STEM CELL; HUMAN; HYPERTENSION; INFLAMMATION; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEURAL CREST CELL; NEURAL STEM CELL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTISCHEMIC REVASCULARIZATION; PROTEIN EXPRESSION; REVASCULARIZATION; REVIEW; SYMPATHETIC NERVE; VASCULAR DISEASE; VASCULARIZATION; ANIMAL; ARTERY; GROWTH, DEVELOPMENT AND AGING; INNERVATION; ISCHEMIA; PATHOLOGY;

ANIMALS; ARTERIES; GROWTH AND DEVELOPMENT; HUMANS; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR DISEASES;

EID: 84907287891     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3008910     Document Type: Review

References (35)

1. N. O. Glebova, D. D. Ginty, Growth and survival signals controlling sympathetic nervous system development. Annu. Rev. Neurosci. 28, 191-222 (2005).
2. S. C. Malpas, Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol. Rev. 90, 513-557 (2010).
3. E. Storkebaum, P. Carmeliet, Paracrine control of vascular innervation in health and disease. Acta Physiol. (Oxf.) 203, 61-86 (2011).
4. E. B. Westcott, S. S. Segal, Perivascular innervation: A multiplicity of roles in vasomotor control and myoendothelial signaling. Microcirculation 20, 217-238 (2013).
5. N. M. Le Douarin, J. Smith, C. S. Le Lièvre, From the neural crest to the ganglia of the peripheral nervous system. Annu. Rev. Physiol. 43, 653-671 (1981).
6. D. Saito, Y. Takase, H. Murai, Y. Takahashi, The dorsal aorta initiates a molecular cascade that instructs sympathoadrenal specification. Science 336, 1578-1581 (2012).
7. Y. Takahashi, D. Sipp, H. Enomoto, Tissue interactions in neural crest cell development and disease. Science 341, 860-863 (2013).
8. H. Rohrer, Transcriptional control of diff erentiation and neurogenesis in autonomic ganglia. Eur. J. Neurosci. 34, 1563-1573 (2011).
9. N. O. Glebova, D. D. Ginty, Heterogeneous requirement of NGF for sympathetic target innervation in vivo. J. Neurosci. 24, 743-751 (2004).
10. J. Nam, I. Onitsuka, J. Hatch, Y. Uchida, S. Ray, S. Huang, W. Li, H. Zang, P. Ruiz-Lozano, Y. S. Mukouyama, Coronary veins determine the pattern of sympathetic innervation in the developing heart. Development 140, 1475-1485 (2013).
11. R. H. Baloh, M. G. Tansey, P. A. Lampe, T. J. Fahrner, H. Enomoto, K. S. Simburger, M. L. Leitner, T. Araki, E. M. Johnson Jr., J. Milbrandt, Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRα3-RET receptor complex. Neuron 21, 1291-1302 (1998).
12. H. Enomoto, P. A. Crawford, A. Gorodinsky, R. O. Heuckeroth, E. M. Johnson Jr., J. Milbrandt, RET signaling is essential for migration, axonal growth and axon guidance of developing sympathetic neurons. Development 128, 3963-3974 (2001).
13. Y. Honma, T. Araki, S. Gianino, A. Bruce, R. Heuckeroth, E. Johnson Jr., J. Milbrandt, Artemin is a vascular-derived neurotropic factor for developing sympathetic neurons. Neuron 35, 267-282 (2002).
14. R. Kuruvilla, L. S. Zweifel, N. O. Glebova, B. E. Lonze, G. Valdez, H. Ye, D. D. Ginty, A neurotrophin signaling cascade coordinates sympathetic neuron development through diff erential control of TrkA trafficking and retrograde signaling. Cell 118, 243-255 (2004).
15. T. Makita, H. M. Sucov, C. E. Gariepy, M. Yanagisawa, D. D. Ginty, Endothelins are vascular-derived axonal guidance cues for developing sympathetic neurons. Nature 452, 759-763 (2008).
16. E. Rubin, Development of the rat superior cervical ganglion: Ganglion cell maturation. J. Neurosci. 5, 673-684 (1985).
17. I. Brunet, E. Gordon, J. Han, B. Cristofaro, D. Broqueres-You, C. Liu, K. Bouvrée, J. Zhang, R. del Toro, T. Mathivet, B. Larrivée, J. Jagu, L. Pibouin-Fragner, L. Pardanaud, M. J. Machado, T. E. Kennedy, Z. Zhuang, M. Simons, B. I. Levy, M. Tessier-Lavigne, A. Grenz, H. Eltzschig, A. Eichmann, Netrin-1 controls sympathetic arterial innervation. J. Clin. Invest. 124, 3230-3240 (2014).
18. G. Burnstock, Non-synaptic transmission at autonomic neuroeff ector junctions. Neurochem. Int. 52, 14-25 (2008).
19. E. Storkebaum, C. Ruiz de Almodovar, M. Meens, S. Zacchigna, M. Mazzone, G. Vanhoutte, S. Vinckier, K. Miskiewicz, K. Poesen, D. Lambrechts, G. M. Janssen, G. E. Fazzi, P. Verstreken, J. Haigh, P. M. Schiffers, H. Rohrer, A. Van der Linden, J. G. De Mey, P. Carmeliet, Impaired autonomic regulation of resistance arteries in mice with low vascular endothelial growth factor or upon vascular endothelial growth factor trap delivery. Circulation 122, 273-281 (2010).
20. J. B. Long, S. M. Jay, S. S. Segal, J. A. Madri, VEGF-A and Semaphorin3A: Modulators of vascular sympathetic innervation. Dev. Biol. 334, 119-132 (2009).
21. M. Ieda, H. Kanazawa, K. Kimura, F. Hattori, Y. Ieda, M. Taniguchi, J. K. Lee, K. Matsumura, Y. Tomita, S. Miyoshi, K. Shimoda, S. Makino, M. Sano, I. Kodama, S. Ogawa, K. Fukuda, Sema3a maintains normal heart rhythm through sympathetic innervation patterning. Nat. Med. 13, 604-612 (2007).
22. C. H. Maden, J. Gomes, Q. Schwarz, K. Davidson, A. Tinker, C. Ruhrberg, NRP1 and NRP2 cooperate to regulate gangliogenesis, axon guidance and target innervation in the sympathetic nervous system. Dev. Biol. 369, 277-285 (2012).
23. P. Carmeliet, Angiogenesis in health and disease. Nat. Med. 9, 653-660 (2003).
24. J. S. Silvestre, Vascular progenitor cells and diabetes: Role in postischemic neovascularisation. Diabetes Metab. 34 (suppl. 1), S33-S36 (2008).
25. D. Chalothorn, H. Zhang, J. A. Clayton, S. A. Thomas, J. E. Faber, Catecholamines augment collateral vessel growth and angiogenesis in hindlimb ischemia. Am. J. Physiol. Heart Circ. Physiol. 289, H947-H959 (2005).
26. 2-adrenoceptor gene transfer and role of NFκB and CREB transcription factors. Br. J. Pharmacol. 162, 712-721 (2011).
27. Y. Katayama, M. Battista, W. M. Kao, A. Hidalgo, A. J. Peired, S. A. Thomas, P. S. Frenette, Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124, 407-421 (2006).
28. S. Méndez-Ferrer, D. Lucas, M. Battista, P. S. Frenette, Haematopoietic stem cell release is regulated by circadian oscillations. Nature 452, 442-447 (2008).
29. A. Récalde, A. Richart, C. Guérin, C. Cochain, Y. Zouggari, K. H. Yin, J. Vilar, I. Drouet, B. Lévy, O. Varoquaux, J. S. Silvestre, Sympathetic nervous system regulates bone marrow-derived cell egress through endothelial nitric oxide synthase activation: Role in postischemic tissue remodeling. Arterioscler. Thromb. Vasc. Biol. 32, 643-653 (2012).
30. V. F. Segers, R. T. Lee, Stem-cell therapy for cardiac disease. Nature 451, 937-942 (2008).
31. V. M. Sanders, Interdisciplinary research: Noradrenergic regulation of adaptive immunity. Brain Behav. Immun. 20, 1-8 (2006).
32. G. Grassi, G. Seravalle, F. Quarti-Trevano, The 'neuroadrenergic hypothesis' in hypertension: Current evidence. Exp. Physiol. 95, 581-586 (2010).
33. T. M. Coffman, Under pressure: The search for the essential mechanisms of hypertension. Nat. Med. 17, 1402-1409 (2011).
34. A. Pathak, X. Girerd, M. Azizi, H. Benamer, J. M. Halimi, P. Lantelme, T. Lefèvre, M. Sapoval, French Society of Hypertension, French Society of Cardiology, Working Group on Atheroma, Interventional Cardiology, French Society of Radiology, Expert consensus: Renal denervation for the treatment of arterial hypertension. Arch. Cardiovasc. Dis. 105, 386-393 (2012).
35. D. L. Bhatt, D. E. Kandzari, W. W. O'Neill, R. D'Agostino, J. M. Flack, B. T. Katzen, M. B. Leon, M. Liu, L. Mauri, M. Negoita, S. A. Cohen, S. Oparil, K. Rocha-Singh, R. R. Townsend, G. L. Bakris, SYMPLICITY HTN-3 Investigators, A controlled trial of renal denervation for resistant hypertension. N. Engl. J. Med. 370, 1393-1401 (2014).